The Planetary Challenge Is Now Industrial

We have never known more about the planet’s condition. As of late 2025, seven of the nine planetary boundaries identified by the Stockholm Resilience Centre have been crossed, including climate change, biosphere integrity, and ocean acidification. Yet knowledge has not produced decisive action. What separates planetary knowledge from planetary action is conversion and accountability: turning satellite observations into verified carbon credits that regulators and markets accept, biological discoveries into manufactured products that industrial buyers can trust at scale, and ecosystem signals into decisions that capital markets and public institutions can hold accountable.

Converting science into verified, scalable, market-ready solutions is the real challenge. The barriers are structural, spanning technical, commercial and institutional dimensions. They help explain why capital continues to favor fast-scaling digital solutions, while many capital-intensive, operationally complex technologies essential to planetary stabilisation remain underfunded. This bottleneck requires cross-disciplinary teams to navigate regulatory pathways, manufacturing constraints, and market structures that no single domain of expertise can map alone. Understanding these challenges first and then converting them into actions is an engineering problem, a commercial problem, and an institutional problem simultaneously, and it is precisely the problem the HEC Deep Tech Center addresses through CDL-Paris, Challenge+, and the Nurture Program.

Climate Solutions Need Industrial Scale

The climate ventures that will matter over the next decade won't look like software startups. They look like infrastructure companies working on problems where emissions are structurally embedded and technically difficult to eliminate: cement, steel, industrial heat, long-duration energy storage, advanced materials, and scalable carbon removal. These are sectors where the incumbent industrial process is approaching both an ecological limit and an economic one, and where the regulatory environment is actively constructing the market conditions that make transformation investable rather than praiseworthy in principle.

Yama’s hybrid electrochemical direct air capture approach is designed to reduce dependence on land-intensive biomass, water-heavy sorbent systems, and complex manufacturing supply chains that constrain many carbon-removal pathways. CURA Climate applies electrochemical chemistry to cement production, targeting the process emissions released during limestone calcination while fitting into existing industrial infrastructure and feedstock choices. Altrove addresses critical-material scarcity by combining AI-guided materials prediction with automated laboratory validation, accelerating the discovery of rare-earth alternatives. In each case, the regulatory pressure and the commercial solution are converging on the same timeline, closing the translation gap between what the science can do and what the market is ready to buy. 

Biology as the Next Industrial Platform

Biology is shifting from an academic discipline into a foundational manufacturing technology, comparable to computing in the 1980s. Synthetic biology, AI protein engineering, and advanced fermentation now enable programmable living systems that can outperform incumbent processes on cost, precision, and environmental impact.

The 2026 CDL-Paris BioTech thesis is organised around three pillars that reflect how this transition actually moves from scientific possibility to industrial reality: next-generation diagnostic platforms, including advanced biosensors, microbiome analysis, and real-time environmental and health monitoring tools; the convergence of AI and biology, from molecular modelling to the responsible governance of sensitive biological data; and, critically, the manufacturing infrastructure that determines whether a biological discovery can be produced at scale.

The critical bottleneck remains scaling and manufacturing. European biotech firms frequently relocate or list abroad because biofoundry capacity is dominated by large pharma contracts. This structural issue, directly addressed in the EU Biotech Act proposed in December 2025, forces the best ventures to treat manufacturing as core architecture from day one. The analogy with the Space stream is instructive: just as a single satellite platform must justify its infrastructure cost by serving climate monitoring, agricultural intelligence, and sovereign defense applications simultaneously, a biological platform technology must be designed from the start to serve multiple markets and use cases, because the foundry economics only work when the asset is fully utilized across genuinely diverse high-value applications.

Space: From Observation to Decision-Grade Intelligence

Space addresses a specific failure mode: unverified environmental claims have little commercial value. The meaningful shift is from raw Earth observation data to actionable intelligence: insights that insurers will price, carbon markets will certify, and operators will act upon in real time.

The 2026 CDL-Paris Space thesis starts from the recognition that accelerating activity in orbit is already reshaping communications, security, industrial production, and the global economy, and that incremental improvements to legacy spacecraft and ground infrastructure will not keep pace with a congested, contested, and increasingly critical space environment. The future requires systems that actively sense and understand everything happening in orbit, service and assemble complex architectures in situ, and enable intelligent, secure operations at scale. 

What this means in practice is a pivot from observation to decision-grade intelligence: AI edge processing turns petabytes of imagery into real-time predictions, alerts, and automated actions, shrinking data volumes and empowering organizations that have never employed an Earth observation expert to forecast crop yields, detect methane leaks, or flag infrastructure threats before their ground teams intervene.

The commercial logic that follows is precise: demand from agriculture, insurance, and climate risk analytics downstream will pull commercialization upstream toward the Earth observation intelligence providers and the in-orbit compute infrastructure that processes data in situ. In January 2025, ESA signed a €175.5 million contract for a third CO2M satellite, expanding Copernicus greenhouse gas monitoring to a three-satellite system with a three-day revisit time. Copernicus's sovereign, openly licensed data gives European ventures a regulatory trust infrastructure that commercially operated constellations elsewhere cannot replicate, making this downstream pull commercially material precisely where it matters most: the full chain from emission source to certified removal.

The Convergence Thesis

The intersection of Climate, BioTech, and Space at CDL-Paris reflects a deeper reality: planetary-scale challenges are solved not by isolated breakthroughs but by integrated industrial systems that connect scientific insight to deployment at scale. Europe’s edge lies in combining sovereign data infrastructure (Copernicus), targeted industrial policy (EU Biotech Act and hard-to-abate mandates, including the successful EU ETS Scheme), and a regulatory environment that is, for all the friction it generates in the short term, actively writing the market conditions that the next generation of deep tech ventures needs to scale.